Paul Hoerbelt

Paul Hoerbelt is the Director of Biotechnologies at Research Corporation Technologies, where he investigates new investment and business growth opportunities in life science tools and therapeutics. Prior to this role, he worked as an Associate at Illumina Ventures from 2021 to 2023 and served as a Senior Life Sciences Specialist at LEK Consulting between 2020 and 2021. He previously spent five years as a Postdoctoral Scholar at Stanford University from 2015 to 2020, following a six-year tenure as a Graduate Student Researcher at Albany Medical College. He holds a PhD in Neuropharmacology and Neuroscience from Albany Medical College, a BS in Biology and Philosophy from SUNY Albany, and a Stanford Ignite Certificate in Innovation and Entrepreneurship. His professional background combines deep academic research with strategic management consulting and venture capital expertise to evaluate emerging biotechnology investments.